Mirae Asset Global Investments’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38K | Buy |
1,896
+261
| +16% | +$5.24K | ﹤0.01% | 1300 |
|
|
2025
Q1 | $34.4K | Buy |
1,635
+7
| +0.4% | +$147 | ﹤0.01% | 1308 |
|
|
2024
Q4 | $36.4K | Sell |
1,628
-80
| -5% | -$1.79K | ﹤0.01% | 1319 |
|
|
2024
Q3 | $41.2K | Buy |
1,708
+304
| +22% | +$7.34K | ﹤0.01% | 1336 |
|
|
2024
Q2 | $32.9K | Buy |
+1,404
| New | +$32.9K | ﹤0.01% | 1316 |
|
|
2024
Q1 | – | Sell |
-12,305
| Closed | -$170K | – | 2491 |
|
|
2023
Q4 | $170K | Buy |
12,305
+1,029
| +9% | +$14.2K | ﹤0.01% | 2368 |
|
|
2023
Q3 | $154K | Hold |
11,276
| – | – | ﹤0.01% | 2365 |
|
|
2023
Q2 | $230K | Buy |
+11,276
| New | +$230K | ﹤0.01% | 2289 |
|